MoonLake Immunotherapeutics Class A Ordinary Shares MLTX
$12.34
+15.87%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (8 Buy · 1 Hold · 2 Sell)
- Average Price Target
- $30.55
- Implied Upside
- +147.5%
- Price Target Range
- $5.00 – $70.00
- Analysts (12 mo)
- 11
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-05 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $50 |
| 2026-08-13 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $45 → $50 |
| 2026-07-20 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $45 |
| 2026-07-01 | Leerink PartnersThomas Smith |
Maintains | Outperform | $24 → $29 |
| 2026-06-09 | BTIGJulian Harrison |
Reiterates | Buy | $30 |
| 2026-06-08 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $45 |
| 2026-05-12 | NeedhamSerge Belanger |
Maintains | Buy | $25 → $30 |
| 2026-05-11 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $40 → $45 |
| 2026-03-30 | BTIGJulian Harrison |
Reiterates | Buy | $30 |
| 2026-03-23 | Wolfe ResearchAndy Chen |
Upgrades | Underperform → Outperform | $12 → $24 |
| 2026-03-19 | Rothschild & CoQize Ding |
Upgrades | Neutral → Buy | $12 → $40 |
| 2026-03-11 | Clear StreetKaveri Pohlman |
Maintains | Buy | $45 → $70 |
| 2026-03-02 | RBC CapitalBrian Abrahams |
Maintains | Sector perform | $12 → $13 |
| 2026-03-02 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $32 → $40 |
| 2026-02-26 | NeedhamSerge Belanger |
Reiterates | Buy | $25 |
| 2026-02-24 | OppenheimerAndreas Argyrides |
Maintains | Outperform | $30 → $35 |
| 2026-02-23 | BTIGJulian Harrison |
Maintains | Buy | $24 → $30 |
| 2026-02-23 | NeedhamSerge Belanger |
Maintains | Buy | $20 → $25 |
| 2026-02-20 | RBC CapitalBrian Abrahams |
Maintains | Sector perform | $10 → $12 |
| 2026-02-09 | BTIGJulian Harrison |
Reiterates | Buy | $24 |
| 2026-02-03 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $32 |
| 2026-01-15 | Goldman Sachs Richard Law |
Downgrades | Neutral → Sell | $8 → $10 |
| 2026-01-09 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $26 → $32 |
| 2026-01-09 | BTIGJulian Harrison |
Upgrades | Neutral → Buy | $24 |
| 2025-11-21 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $30 → $26 |
| 2025-11-03 | HC Wainwright & Co.Raghuram Selvaraju |
Upgrades | Neutral → Buy | $30 |
| 2025-10-29 | CitigroupSamantha Semenkow |
Downgrades | Neutral → Sell | $5 |
| 2025-10-02 | HC Wainwright & Co.Raghuram Selvaraju |
Downgrades | Buy → Neutral | — |
| 2025-09-30 | GuggenheimYatin Suneja |
Maintains | Buy | $80 → $20 |
| 2025-09-30 | WedbushYun Zhong |
Maintains | Outperform | $80 → $18 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $12.34
- Market Cap
- $906.39 million
- 52-Week Range
- $5.95 – $62.75
- Average Volume
- 2.02 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.